Publications (63) MARÍA ÁNGELES ORELLANA MIGUEL publications

filter_list

2024

  1. Assessment of risk-adjusted mortality ratio (RAMR) in bloodstream infections using all-patient refined diagnosis-related groups (APR-DRGs)

    The Journal of antimicrobial chemotherapy, Vol. 79, Núm. 5, pp. 1019-1022

  2. Bacteremia due to Leuconostoc species: A 13-year single-center case series

    Enfermedades Infecciosas y Microbiologia Clinica, Vol. 42, Núm. 3, pp. 149-151

  3. Infective endocarditis in pediatric patients: a decade of insights from a leading Spanish heart surgery reference center

    European Journal of Pediatrics, Vol. 183, Núm. 9, pp. 3905-3913

  4. Predictive value of fecal calprotectin and lactoferrin levels for negative outcomes in Clostridioides difficile infection

    European Journal of Clinical Microbiology and Infectious Diseases, Vol. 43, Núm. 2, pp. 313-324

  5. Pseudomonas aeruginosa bloodstream infections in children and adolescents: risk factors associated with carbapenem resistance and mortality

    Journal of Hospital Infection, Vol. 149, pp. 56-64

2023

  1. Antibiotic resistance in bloodstream isolates from high-complexity paediatric units in Madrid, Spain: 2013–2021

    Journal of Hospital Infection, Vol. 139, pp. 33-43

  2. Bacteremia in Patients with Solid Organ Cancer: Insights into Epidemiology and Antibiotic Consumption

    Cancers, Vol. 15, Núm. 23

  3. Cloxacillin plus fosfomycin versus cloxacillin alone for methicillin-susceptible Staphylococcus aureus bacteremia: a randomized trial

    Nature Medicine, Vol. 29, Núm. 10, pp. 2518-2525

  4. Contemporary use of cefazolin for MSSA infective endocarditis: analysis of a national prospective cohort

    International Journal of Infectious Diseases, Vol. 137, pp. 134-143

  5. Evaluation of the effectiveness and safety of oral vancomycin versus placebo in the prevention of recurrence of Clostridioides difficile infection in patients under systemic antibiotic therapy: a phase III, randomised, double-blind clinical trial

    BMJ open, Vol. 13, Núm. 9, pp. e072121

  6. Increased risk of group B streptococcal sepsis and meningitis in HIV-exposed uninfected infants in a high-income country

    European Journal of Pediatrics, Vol. 182, Núm. 2, pp. 575-579

  7. Influence on sputum microbiology with CFTR modulator (tezacaftor-ivacaftor) in adult patients with cystic fibrosis: Multicenter study

    Enfermedades Infecciosas y Microbiologia Clinica, Vol. 41, Núm. 3, pp. 193-195

2022

  1. Clinical impact of time-to-positivity of blood cultures on mortality in patients with Pseudomonas aeruginosa bacteremia

    Journal of Global Antimicrobial Resistance, Vol. 30, pp. 269-275

  2. Determining Time to Positivity of Blood Cultures in a Neonatal Unit

    Journal of the Pediatric Infectious Diseases Society, Vol. 11, Núm. 11, pp. 510-513

  3. Genomic Analysis of Ceftazidime/Avibactam-Resistant GES-Producing Sequence Type 235 Pseudomonas aeruginosa Isolates

    Antibiotics, Vol. 11, Núm. 7

  4. Pertactin-Deficient Bordetella pertussis with Unusual Mechanism of Pertactin Disruption, Spain, 1986–2018

    Emerging Infectious Diseases, Vol. 28, Núm. 5, pp. 967-976

2021

  1. Clinical Features and Outcomes of Streptococcus anginosus Group Infective Endocarditis: A Multicenter Matched Cohort Study

    Open Forum Infectious Diseases, Vol. 8, Núm. 6

  2. Clinical and bacterial characteristics of Pseudomonas aeruginosa affecting the outcome of patients with bacteraemic pneumonia

    International Journal of Antimicrobial Agents, Vol. 58, Núm. 6

  3. Eradication of staphylococcus aureus post-sternotomy mediastinitis following the implementation of universal preoperative nasal decontamination with mupirocin: An interrupted time-series analysis

    Clinical Infectious Diseases, Vol. 73, Núm. 9, pp. 1685-1692

  4. Mural Endocarditis: The GAMES Registry Series and Review of the Literature

    Infectious Diseases and Therapy, Vol. 10, Núm. 4, pp. 2749-2764